Dark Forest Capital Management LP Cassava Sciences Inc Transaction History

Dark Forest Capital Management LP

  • $718 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$12.35 - $26.11 $131,342 - $277,679
10,635 New
10,635 $131,000
Q3 2023

Nov 13, 2023
BUY
$16.64 - $25.32 $16,540 - $25,168
994 Added 10.72%
10,264 $170,000
Q2 2023

Aug 14, 2023
BUY
$21.59 - $27.88 $170,388 - $220,028
7,892 Added 572.71%
9,270 $227,000
Q1 2023

May 12, 2023
BUY
$23.46 - $36.44 $32,327 - $50,214
1,378 New
1,378 $33,000

Others Institutions Holding SAVA

# of Institutions
201
Shares Held
13.9M
Call Options Held
2.98M
Put Options Held
6.57M
View Full List

About CASSAVA SCIENCES INC

SAVA Quotes by TradingView
  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $110M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email